doi	title	authors	title_name	year	downloads	visitors	countries
10.1158/2159-8290.cd-14-1211	HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment	S. M. Kavuri, N. Jain, F. Galimi, F. Cottino, S. M. Leto, G. Migliardi, A. C. Searleman, W. Shen, J. Monsey, L. Trusolino, S. A. Jacobs, A. Bertotti, R. Bose	Cancer Discovery	2015	47	42	11
10.1158/2159-8290.cd-15-0370	Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma	R. J. H. Ryan, Y. Drier, H. Whitton, M. J. Cotton, J. Kaur, R. Issner, S. Gillespie, C. B. Epstein, V. Nardi, A. R. Sohani, E. P. Hochberg, B. E. Bernstein	Cancer Discovery	2015	50	39	7
10.1158/2159-8290.cd-15-0563	Adaptive Immune Resistance: How Cancer Protects from Immune Attack	A. Ribas	Cancer Discovery	2015	31	29	14
10.1158/2159-8290.cd-14-0337	AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer	D. A. E. Cross, S. E. Ashton, S. Ghiorghiu, C. Eberlein, C. A. Nebhan, P. J. Spitzler, J. P. Orme, M. R. V. Finlay, R. A. Ward, M. J. Mellor, G. Hughes, A. Rahi, V. N. Jacobs, M. R. Brewer, E. Ichihara, J. Sun, H. Jin, P. Ballard, K. Al-Kadhimi, R. Rowlinson, T. Klinowska, G. H. P. Richmond, M. Cantarini, D.-W. Kim, M. R. Ranson, W. Pao	Cancer Discovery	2014	33	28	3
10.1158/2159-8290.cd-15-0063	Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung Cancer	E. M. Tricker, C. Xu, S. Uddin, M. Capelletti, D. Ercan, A. Ogino, C. A. Pratilas, N. Rosen, N. S. Gray, K.-K. Wong, P. A. Janne	Cancer Discovery	2015	30	26	5
10.1158/2159-8290.cd-15-0196	CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma	A. S. McNeal, K. Liu, V. Nakhate, C. A. Natale, E. K. Duperret, B. C. Capell, T. Dentchev, S. L. Berger, M. Herlyn, J. T. Seykora, T. W. Ridky	Cancer Discovery	2015	32	26	8
10.1158/2326-6066.cir-15-0112	Engineering New Approaches to Cancer Vaccines	N. K. Mehta, K. D. Moynihan, D. J. Irvine	Cancer immunology research	2015	34	25	10
10.1158/2159-8290.cd-15-0060	"Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 ""Gatekeeper"" F691L Mutation with PLX3397"	C. C. Smith, C. Zhang, K. C. Lin, E. A. Lasater, Y. Zhang, E. Massi, L. E. Damon, M. Pendleton, A. Bashir, R. Sebra, A. Perl, A. Kasarskis, R. Shellooe, G. Tsang, H. Carias, B. Powell, E. A. Burton, B. Matusow, J. Zhang, W. Spevak, P. N. Ibrahim, M. H. Le, H. H. Hsu, G. Habets, B. L. West, G. Bollag, N. P. Shah	Cancer Discovery	2015	34	24	8
10.1158/2159-8290.cd-15-0090	HOXB7 Is an ER  Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance	K. Jin, S. Park, W. W. Teo, P. Korangath, S. S. Cho, T. Yoshida, B. Gy rffy, C. P. Goswami, H. Nakshatri, L.-A. Cruz, W. Zhou, H. Ji, Y. Su, M. Ekram, Z. Wu, T. Zhu, K. Polyak, S. Sukumar	Cancer Discovery	2015	29	23	5
10.1158/2159-8290.cd-13-1014	Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA	D. A. Haber, V. E. Velculescu	Cancer Discovery	2014	24	22	5
10.1158/2159-8290.cd-15-0012	Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA	A. S. Harney, E. N. Arwert, D. Entenberg, Y. Wang, P. Guo, B.-Z. Qian, M. H. Oktay, J. W. Pollard, J. G. Jones, J. S. Condeelis	Cancer Discovery	2015	24	22	10
10.1158/2159-8290.cd-14-0849	ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors	J. Shen, Y. Peng, L. Wei, W. Zhang, L. Yang, L. Lan, P. Kapoor, Z. Ju, Q. Mo, I.-M. Shih, I. P. Uray, X. Wu, P. H. Brown, X. Shen, G. B. Mills, G. Peng	Cancer Discovery	2015	26	21	5
10.1158/2159-8290.cd-14-0863	The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints	N. J. Llosa, M. Cruise, A. Tam, E. C. Wicks, E. M. Hechenbleikner, J. M. Taube, R. L. Blosser, H. Fan, H. Wang, B. S. Luber, M. Zhang, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, C. L. Sears, R. A. Anders, D. M. Pardoll, F. Housseau	Cancer Discovery	2014	23	21	10
10.1158/2326-6066.cir-14-0191	Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody	R. Stewart, M. Morrow, S. A. Hammond, K. Mulgrew, D. Marcus, E. Poon, A. Watkins, S. Mullins, M. Chodorge, J. Andrews, D. Bannister, E. Dick, N. Crawford, J. Parmentier, M. Alimzhanov, J. S. Babcook, I. N. Foltz, A. Buchanan, V. Bedian, R. W. Wilkinson, M. McCourt	Cancer immunology research	2015	23	20	8
10.1158/2159-8290.cd-13-0846	The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer	L. Friboulet, N. Li, R. Katayama, C. C. Lee, J. F. Gainor, A. S. Crystal, P.-Y. Michellys, M. M. Awad, N. Yanagitani, S. Kim, A. C. Pferdekamper, J. Li, S. Kasibhatla, F. Sun, X. Sun, S. Hua, P. McNamara, S. Mahmood, E. L. Lockerman, N. Fujita, M. Nishio, J. L. Harris, A. T. Shaw, J. A. Engelman	Cancer Discovery	2014	25	19	3
10.1158/2159-8290.cd-14-1490	Endoplasmic Reticulum Stress-Activated Cell Reprogramming in Oncogenesis	E. Chevet, C. Hetz, A. Samali	Cancer Discovery	2015	22	19	11
10.1158/2159-8290.cd-15-0011	The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics	A. N. Hata, J. A. Engelman, A. C. Faber	Cancer Discovery	2015	25	19	8
10.1158/2159-8290.cd-15-0125	A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma	L. Mirabello, R. Koster, B. S. Moriarity, L. G. Spector, P. S. Meltzer, J. Gary, M. J. Machiela, N. Pankratz, O. A. Panagiotou, D. Largaespada, Z. Wang, J. M. Gastier-Foster, R. Gorlick, C. Khanna, S. R. C. de Toledo, A. S. Petrilli, A. Patino-Garcia, L. Sierrasesumaga, F. Lecanda, I. L. Andrulis, J. S. Wunder, N. Gokgoz, M. Serra, C. Hattinger, P. Picci, K. Scotlandi, A. M. Flanagan, R. Tirabosco, M. F. Amary, D. Halai, M. L. Ballinger, D. M. Thomas, S. Davis, D. A. Barkauskas, N. Marina, L. Helman, G. M. Otto, K. L. Becklin, N. K. Wolf, M. T. Weg, M. Tucker, S. Wacholder, J. F. Fraumeni, N. E. Caporaso, J. F. Boland, B. D. Hicks, A. Vogt, L. Burdett, M. Yeager, R. N. Hoover, S. J. Chanock, S. A. Savage	Cancer Discovery	2015	21	19	5
10.1158/2159-8290.cd-15-0399	Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor	Z. Piotrowska, M. J. Niederst, C. A. Karlovich, H. A. Wakelee, J. W. Neal, M. Mino-Kenudson, L. Fulton, A. N. Hata, E. L. Lockerman, A. Kalsy, S. Digumarthy, A. Muzikansky, M. Raponi, A. R. Garcia, H. E. Mulvey, M. K. Parks, R. H. DiCecca, D. Dias-Santagata, A. J. Iafrate, A. T. Shaw, A. R. Allen, J. A. Engelman, L. V. Sequist	Cancer Discovery	2015	26	19	5
10.1158/2159-8290.cd-15-0447	Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis	A. L. Geis, H. Fan, X. Wu, S. Wu, D. L. Huso, J. L. Wolfe, C. L. Sears, D. M. Pardoll, F. Housseau	Cancer Discovery	2015	23	19	3
10.1158/2159-8290.cd-nb2015-105	AIM2 Blocks Colon Cancer in Three Ways		Cancer Discovery	2015	24	19	4
10.1158/2326-6066.cir-14-0225	Microbiota Modulation of Myeloid Cells in Cancer Therapy	R. S. Goldszmid, A. Dzutsev, S. Viaud, L. Zitvogel, N. P. Restifo, G. Trinchieri	Cancer immunology research	2015	19	19	7
10.1158/2326-6066.cir-15-0062	The Regulatory Role of Invariant NKT Cells in Tumor Immunity	R. M. McEwen-Smith, M. Salio, V. Cerundolo	Cancer immunology research	2015	20	19	9
10.1158/2159-8290.cd-14-0788	How Does Multistep Tumorigenesis Really Proceed?	C. L. Chaffer, R. A. Weinberg	Cancer Discovery	2015	20	18	13
10.1158/2159-8290.cd-15-0344	APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity	C. Swanton, N. McGranahan, G. J. Starrett, R. S. Harris	Cancer Discovery	2015	21	18	12
10.1158/2159-8290.cd-15-0460	PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex	P. Liu, W. Gan, Y. R. Chin, K. Ogura, J. Guo, J. Zhang, B. Wang, J. Blenis, L. C. Cantley, A. Toker, B. Su, W. Wei	Cancer Discovery	2015	19	18	6
10.1158/2326-6066.cir-14-0133	PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer	H. Wimberly, J. R. Brown, K. Schalper, H. Haack, M. R. Silver, C. Nixon, V. Bossuyt, L. Pusztai, D. R. Lannin, D. L. Rimm	Cancer immunology research	2014	20	18	10
10.1158/2326-6066.cir-14-0177	Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling	H. Zhang, K. Tang, Y. Zhang, R. Ma, J. Ma, Y. Li, S. Luo, X. Liang, T. Ji, Z. Gu, J. Lu, W. He, X. Cao, Y. Wan, B. Huang	Cancer immunology research	2014	20	18	2
10.1158/2159-8290.cd-14-0552	Linking Tumor Mutations to Drug Responses via a Quantitative Chemical-Genetic Interaction Map	M. M. Martins, A. Y. Zhou, A. Corella, D. Horiuchi, C. Yau, T. Rakshandehroo, J. D. Gordan, R. S. Levin, J. Johnson, J. Jascur, M. Shales, A. Sorrentino, J. Cheah, P. A. Clemons, A. F. Shamji, S. L. Schreiber, N. J. Krogan, K. M. Shokat, F. McCormick, A. Goga, S. Bandyopadhyay	Cancer Discovery	2014	21	17	3
10.1158/2159-8290.cd-14-0943	Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma	F. Cottini, T. Hideshima, R. Suzuki, Y.-T. Tai, G. Bianchini, P. G. Richardson, K. C. Anderson, G. Tonon	Cancer Discovery	2015	18	17	7
10.1158/2159-8290.cd-14-1029	First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway	M. Hagel, C. Miduturu, M. Sheets, N. Rubin, W. Weng, N. Stransky, N. Bifulco, J. L. Kim, B. Hodous, N. Brooijmans, A. Shutes, C. Winter, C. Lengauer, N. E. Kohl, T. Guzi	Cancer Discovery	2015	24	17	2
10.1158/2326-6066.cir-14-0186	Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells	M. J. Frigault, J. Lee, M. C. Basil, C. Carpenito, S. Motohashi, J. Scholler, O. U. Kawalekar, S. Guedan, S. E. McGettigan, A. D. Posey, S. Ang, L. J. N. Cooper, J. M. Platt, F. B. Johnson, C. M. Paulos, Y. Zhao, M. Kalos, M. C. Milone, C. H. June	Cancer immunology research	2015	24	17	7
10.1158/2326-6066.cir-15-0059	Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells	B. Boyerinas, C. Jochems, M. Fantini, C. R. Heery, J. L. Gulley, K. Y. Tsang, J. Schlom	Cancer immunology research	2015	20	17	9
10.1158/2159-8290.cd-15-0246	Paralog-Specific Kinase Inhibition of FGFR4: Adding to the Arsenal of Anti-FGFR Agents	L. M. Packer, P. M. Pollock	Cancer Discovery	2015	17	16	2
10.1158/2159-8290.cd-15-0660	Targeting MYC Translation in Colorectal Cancer	A. Castell, L.-G. Larsson	Cancer Discovery	2015	18	16	2
10.1158/2326-6066.cir-14-0196	Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen	A. B. Sharabi, C. J. Nirschl, C. M. Kochel, T. R. Nirschl, B. J. Francica, E. Velarde, T. L. Deweese, C. G. Drake	Cancer immunology research	2014	19	16	13
10.1158/2326-6066.cir-14-0211	Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses	P. A. Beavis, N. Milenkovski, M. A. Henderson, L. B. John, B. Allard, S. Loi, M. H. Kershaw, J. Stagg, P. K. Darcy	Cancer immunology research	2015	19	16	8
10.1158/2159-8290.cd-14-0295	EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma	B. Miao, Z. Ji, L. Tan, M. Taylor, J. Zhang, H. G. Choi, D. T. Frederick, R. Kumar, J. A. Wargo, K. T. Flaherty, N. S. Gray, H. Tsao	Cancer Discovery	2014	30	15	4
10.1158/2326-6066.cir-15-0095	Tumoral Immune Resistance Mediated by Enzymes That Degrade Tryptophan	N. van Baren, B. J. Van den Eynde	Cancer immunology research	2015	16	15	8
10.1158/2159-8290.cd-15-0739	Clonal Evolution: Multiregion Sequencing of Esophageal Adenocarcinoma Before and After Chemotherapy	S. Devarakonda, R. Govindan	Cancer Discovery	2015	15	14	4
10.1158/2326-6066.cir-14-0192	T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression	S. P. Santoro, S. Kim, G. T. Motz, D. Alatzoglou, C. Li, M. Irving, D. J. Powell, G. Coukos	Cancer immunology research	2014	14	14	3
10.1158/2159-8290.cd-14-0462	Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution	S. Misale, F. Di Nicolantonio, A. Sartore-Bianchi, S. Siena, A. Bardelli	Cancer Discovery	2014	13	13	6
10.1158/2159-8290.cd-14-0921	The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development	J. L. Van Nostrand, A. Brisac, S. S. Mello, S. B. R. Jacobs, R. Luong, L. D. Attardi	Cancer Discovery	2015	14	13	5
10.1158/2159-8290.cd-14-1467	Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping	P. K. Paik, A. Drilon, P.-D. Fan, H. Yu, N. Rekhtman, M. S. Ginsberg, L. Borsu, N. Schultz, M. F. Berger, C. M. Rudin, M. Ladanyi	Cancer Discovery	2015	15	13	6
10.1158/2159-8290.cd-15-0120	Pancreatic Cancer Metastases Harbor Evidence of Polyclonality	R. Maddipati, B. Z. Stanger	Cancer Discovery	2015	19	13	5
10.1158/2326-6066.cir-15-0044	CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer	T. Higuchi, D. B. Flies, N. A. Marjon, G. Mantia-Smaldone, L. Ronner, P. A. Gimotty, S. F. Adams	Cancer immunology research	2015	16	13	6
10.1158/2326-6066.cir-15-0077-t	HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade	D. M. Woods, A. L. Sodre, A. Villagra, A. Sarnaik, E. M. Sotomayor, J. Weber	Cancer immunology research	2015	13	13	3
10.1158/2159-8290.cd-14-1040	Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer	A. Wiegering, F. W. Uthe, T. Jamieson, Y. Ruoss, M. Huttenrauch, M. Kuspert, C. Pfann, C. Nixon, S. Herold, S. Walz, L. Taranets, C.-T. Germer, A. Rosenwald, O. J. Sansom, M. Eilers	Cancer Discovery	2015	12	12	4
10.1158/2159-8290.cd-15-0769	MET Receptor Juxtamembrane Exon 14 Alternative Spliced Variant: Novel Cancer Genomic Predictive Biomarker	P. C. Ma	Cancer Discovery	2015	13	12	7
10.1158/2159-8290.cd-iti5-5	In This Issue		Cancer Discovery	2015	12	12	5
10.1158/2159-8290.cd-nb2015-082	Expanding the Reach of Anti-PD-1 Therapy		Cancer Discovery	2015	15	12	5
10.1158/2326-6066.cir-14-0138	PD-1 Restrains Radiotherapy-Induced Abscopal Effect	S. S. Park, H. Dong, X. Liu, S. M. Harrington, C. J. Krco, M. P. Grams, A. S. Mansfield, K. M. Furutani, K. R. Olivier, E. D. Kwon	Cancer immunology research	2015	12	12	4
10.1158/2326-6066.cir-14-0214	Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors	E. R. Manuel, J. Chen, M. D'Apuzzo, M. G. Lampa, T. I. Kaltcheva, C. B. Thompson, T. Ludwig, V. Chung, D. J. Diamond	Cancer immunology research	2015	12	12	8
10.1158/2326-6066.cir-15-0009	The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy	T. A. Waldmann	Cancer immunology research	2015	15	12	8
10.1158/2159-8290.cd-14-1092	Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers	J. Watkins, D. Weekes, V. Shah, P. Gazinska, S. Joshi, B. Sidhu, C. Gillett, S. Pinder, F. Vanoli, M. Jasin, M. Mayrhofer, A. Isaksson, M. C. U. Cheang, H. Mirza, J. Frankum, C. J. Lord, A. Ashworth, S. Vinayak, J. M. Ford, M. L. Telli, A. Grigoriadis, A. N. J. Tutt	Cancer Discovery	2015	16	11	4
10.1158/2159-8290.cd-14-1236	Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities	F. Skoulidis, L. A. Byers, L. Diao, V. A. Papadimitrakopoulou, P. Tong, J. Izzo, C. Behrens, H. Kadara, E. R. Parra, J. R. Canales, J. Zhang, U. Giri, J. Gudikote, M. A. Cortez, C. Yang, Y. Fan, M. Peyton, L. Girard, K. R. Coombes, C. Toniatti, T. P. Heffernan, M. Choi, G. M. Frampton, V. Miller, J. N. Weinstein, R. S. Herbst, K.-K. Wong, J. Zhang, P. Sharma, G. B. Mills, W. K. Hong, J. D. Minna, J. P. Allison, A. Futreal, J. Wang, I. I. Wistuba, J. V. Heymach	Cancer Discovery	2015	12	11	3
10.1158/2326-6066.cir-14-0145	PD-L1 Expression in Melanocytic Lesions Does Not Correlate with the BRAF V600E Mutation	N. Rodi, R. A. Anders, J. R. Eshleman, M.-T. Lin, H. Xu, J. H. Kim, K. Beierl, S. Chen, B. S. Luber, H. Wang, S. L. Topalian, D. M. Pardoll, J. M. Taube	Cancer immunology research	2014	12	11	2
10.1158/2326-6066.cir-14-0244	Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma	X.-D. Liu, A. Hoang, L. Zhou, S. Kalra, A. Yetil, M. Sun, Z. Ding, X. Zhang, S. Bai, P. German, P. Tamboli, P. Rao, J. A. Karam, C. Wood, S. Matin, A. Zurita, A. Bex, A. W. Griffioen, J. Gao, P. Sharma, N. Tannir, K. Sircar, E. Jonasch	Cancer immunology research	2015	11	11	6
10.1158/2326-6066.cir-15-0057	Targeting Heat-Shock Protein 90 (HSP90) as a Complementary Strategy to Immune Checkpoint Blockade for Cancer Therapy	D. A. Proia, G. F. Kaufmann	Cancer immunology research	2015	12	11	6
10.1158/2159-8290.cd-13-0760	Aberrant Glycosylation Promotes Lung Cancer Metastasis through Adhesion to Galectins in the Metastatic Niche	N. E. Reticker-Flynn, S. N. Bhatia	Cancer Discovery	2014	12	10	5
10.1158/2159-8290.cd-14-1347	In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes	C. Li Chew, A. Lunardi, F. Gulluni, D. T. Ruan, M. Chen, L. Salmena, M. Nishino, A. Papa, C. Ng, J. Fung, J. G. Clohessy, J. Sasaki, T. Sasaki, R. T. Bronson, E. Hirsch, P. P. Pandolfi	Cancer Discovery	2015	10	10	6
10.1158/2159-8290.cd-14-1473	Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma	X. Xie, J. Y. Koh, S. Price, E. White, J. M. Mehnert	Cancer Discovery	2015	16	10	5
10.1158/2159-8290.cd-15-0298	Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy	G. K. Behbehani, N. Samusik, Z. B. Bjornson, W. J. Fantl, B. C. Medeiros, G. P. Nolan	Cancer Discovery	2015	13	10	7
10.1158/2159-8290.cd-15-0654	EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib	J.-N. Gallant, J. H. Sheehan, T. M. Shaver, M. Bailey, D. Lipson, R. Chandramohan, M. R. Brewer, S. J. York, M. G. Kris, J. A. Pietenpol, M. Ladanyi, V. A. Miller, S. M. Ali, J. Meiler, C. M. Lovly	Cancer Discovery	2015	14	10	4
10.1158/2159-8290.cd-15-0730	ERBB2 Emerges as a New Target for Colorectal Cancer	E. Pectasides, A. J. Bass	Cancer Discovery	2015	11	10	2
10.1158/2326-6066.cir-14-0127	The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity	M. Hudecek, D. Sommermeyer, P. L. Kosasih, A. Silva-Benedict, L. Liu, C. Rader, M. C. Jensen, S. R. Riddell	Cancer immunology research	2014	10	10	5
10.1158/2326-6066.cir-14-0220-t	Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor	S. Tahtinen, S. Gronberg-Vaha-Koskela, D. Lumen, M. Merisalo-Soikkeli, M. Siurala, A. J. Airaksinen, M. Vaha-Koskela, A. Hemminki	Cancer immunology research	2015	11	10	4
10.1158/2326-6066.cir-14-0226	Induced PD-L1 Expression Mediates Acquired Resistance to Agonistic Anti-CD40 Treatment	A. Zippelius, J. Schreiner, P. Herzig, P. Muller	Cancer immunology research	2015	12	10	4
10.1158/2326-6066.cir-15-0043	Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma	M. Callea, L. Albiges, M. Gupta, S.-C. Cheng, E. M. Genega, A. P. Fay, J. Song, I. Carvo, R. S. Bhatt, M. B. Atkins, F. S. Hodi, T. K. Choueiri, D. F. McDermott, G. J. Freeman, S. Signoretti	Cancer immunology research	2015	11	10	6
10.1158/2326-6066.cir-15-0053	STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients	R. M. Srivastava, S. Trivedi, F. Concha-Benavente, J. Hyun-bae, L. Wang, R. R. Seethala, B. F. Branstetter, S. Ferrone, R. L. Ferris	Cancer immunology research	2015	10	10	5
10.1158/2326-6066.cir-15-0120	Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions	D. J. DiLillo, J. V. Ravetch	Cancer immunology research	2015	10	10	4
10.1158/2159-8290.cd-14-0001	Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research	M. Hidalgo, F. Amant, A. V. Biankin, E. Budinska, A. T. Byrne, C. Caldas, R. B. Clarke, S. de Jong, J. Jonkers, G. M. Maelandsmo, S. Roman-Roman, J. Seoane, L. Trusolino, A. Villanueva, None None	Cancer Discovery	2014	12	9	3
10.1158/2159-8290.cd-14-0250	Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia	J. Ye, J. Fan, S. Venneti, Y.-W. Wan, B. R. Pawel, J. Zhang, L. W. S. Finley, C. Lu, T. Lindsten, J. R. Cross, G. Qing, Z. Liu, M. C. Simon, J. D. Rabinowitz, C. B. Thompson	Cancer Discovery	2014	10	9	5
10.1158/2159-8290.cd-14-0363	Autophagy Is Required for Glucose Homeostasis and Lung Tumor Maintenance	G. Karsli-Uzunbas, J. Y. Guo, S. Price, X. Teng, S. V. Laddha, S. Khor, N. Y. Kalaany, T. Jacks, C. S. Chan, J. D. Rabinowitz, E. White	Cancer Discovery	2014	9	9	4
10.1158/2159-8290.cd-14-0625	PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers	Y. Li, N. Chitnis, H. Nakagawa, Y. Kita, S. Natsugoe, Y. Yang, Z. Li, M. Wasik, A. J. P. Klein-Szanto, A. K. Rustgi, J. A. Diehl	Cancer Discovery	2015	12	9	5
10.1158/2159-8290.cd-14-1118	Database of Genomic Biomarkers for Cancer Drugs and Clinical Targetability in Solid Tumors	R. Dienstmann, I. S. Jang, B. Bot, S. Friend, J. Guinney	Cancer Discovery	2015	9	9	2
10.1158/2159-8290.cd-14-1518	Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations	L. G. Ahronian, E. M. Sennott, E. M. Van Allen, N. Wagle, E. L. Kwak, J. E. Faris, J. T. Godfrey, K. Nishimura, K. D. Lynch, C. H. Mermel, E. L. Lockerman, A. Kalsy, J. M. Gurski, S. Bahl, K. Anderka, L. M. Green, N. J. Lennon, T. G. Huynh, M. Mino-Kenudson, G. Getz, D. Dias-Santagata, A. J. Iafrate, J. A. Engelman, L. A. Garraway, R. B. Corcoran	Cancer Discovery	2015	9	9	5
10.1158/2159-8290.cd-15-0221	Old Habits Die Hard: Addiction of BRAF-Mutant Cancer Cells to MAP Kinase Signaling	C. B. Meador, W. Pao	Cancer Discovery	2015	9	9	3
10.1158/2159-8290.cd-15-0285	Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors	G. M. Frampton, S. M. Ali, M. Rosenzweig, J. Chmielecki, X. Lu, T. M. Bauer, M. Akimov, J. A. Bufill, C. Lee, D. Jentz, R. Hoover, S.-H. I. Ou, R. Salgia, T. Brennan, Z. R. Chalmers, S. Jaeger, A. Huang, J. A. Elvin, R. Erlich, A. Fichtenholtz, K. A. Gowen, J. Greenbowe, A. Johnson, D. Khaira, C. McMahon, E. M. Sanford, S. Roels, J. White, J. Greshock, R. Schlegel, D. Lipson, R. Yelensky, D. Morosini, J. S. Ross, E. Collisson, M. Peters, P. J. Stephens, V. A. Miller	Cancer Discovery	2015	12	9	5
10.1158/2159-8290.cd-nb2015-057	Pembrolizumab Shows Promise for NSCLC		Cancer Discovery	2015	9	9	5
10.1158/2326-6066.cir-14-0239	PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer	J. R. Webb, K. Milne, B. H. Nelson	Cancer immunology research	2015	14	9	6
10.1158/2159-8290.cd-14-1397	The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy	Y. Xiao, G. J. Freeman	Cancer Discovery	2015	9	8	3
10.1158/2159-8290.cd-15-0443	An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101	R. C. Doebele, L. E. Davis, A. Vaishnavi, A. T. Le, A. Estrada-Bernal, S. Keysar, A. Jimeno, M. Varella-Garcia, D. L. Aisner, Y. Li, P. J. Stephens, D. Morosini, B. B. Tuch, M. Fernandes, N. Nanda, J. A. Low	Cancer Discovery	2015	12	8	2
10.1158/2159-8290.cd-15-0609	INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency	T.-T. T. Vo, D. A. Fruman	Cancer Discovery	2015	9	8	2
10.1158/2159-8290.cd-nb2015-098	New Insight into Mucinous Ovarian Cancer		Cancer Discovery	2015	8	8	4
10.1158/2159-8290.cd-rw2015-145	Affinity-Enhanced TCR-Engineered T Cells Induce Antimyeloma Responses		Cancer Discovery	2015	8	8	4
10.1158/2326-6066.cir-14-0190	Robust Antitumor Effects of Combined Anti-CD4-Depleting Antibody and Anti-PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice	S. Ueha, S. Yokochi, Y. Ishiwata, H. Ogiwara, K. Chand, T. Nakajima, K. Hachiga, S. Shichino, Y. Terashima, E. Toda, F. H. W. Shand, K. Kakimi, S. Ito, K. Matsushima	Cancer immunology research	2015	14	8	4
10.1158/2326-6066.cir-14-0219	PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo	R. Takemura, H. Takaki, S. Okada, H. Shime, T. Akazawa, H. Oshiumi, M. Matsumoto, T. Teshima, T. Seya	Cancer immunology research	2015	8	8	4
10.1158/2326-6066.cir-15-0065	Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer	J. Rautela, N. Baschuk, C. Y. Slaney, K. M. Jayatilleke, K. Xiao, B. N. Bidwell, E. C. Lucas, E. D. Hawkins, P. Lock, C. S. Wong, W. Chen, R. L. Anderson, P. J. Hertzog, D. M. Andrews, A. Moller, B. S. Parker	Cancer immunology research	2015	9	8	8
10.1158/2159-8290.cd-13-1037	The Genomic Landscape of Pediatric Ewing Sarcoma	B. D. Crompton, C. Stewart, A. Taylor-Weiner, G. Alexe, K. C. Kurek, M. L. Calicchio, A. Kiezun, S. L. Carter, S. A. Shukla, S. S. Mehta, A. R. Thorner, C. de Torres, C. Lavarino, M. Sunol, A. McKenna, A. Sivachenko, K. Cibulskis, M. S. Lawrence, P. Stojanov, M. Rosenberg, L. Ambrogio, D. Auclair, S. Seepo, B. Blumenstiel, M. DeFelice, I. Imaz-Rosshandler, A. Schwarz-Cruz y Celis, M. N. Rivera, C. Rodriguez-Galindo, M. D. Fleming, T. R. Golub, G. Getz, J. Mora, K. Stegmaier	Cancer Discovery	2014	8	7	2
10.1158/2159-8290.cd-14-0856	PI3'-Kinase Inhibition Forestalls the Onset of MEK1/2 Inhibitor Resistance in BRAF-Mutated Melanoma	M. M. Deuker, V. Marsh Durban, W. A. Phillips, M. McMahon	Cancer Discovery	2014	7	7	3
10.1158/2159-8290.cd-14-1096	Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma	M. Jafri, N. C. Wake, D. B. Ascher, D. E. V. Pires, D. Gentle, M. R. Morris, E. Rattenberry, M. A. Simpson, R. C. Trembath, A. Weber, E. R. Woodward, A. Donaldson, T. L. Blundell, F. Latif, E. R. Maher	Cancer Discovery	2015	8	7	5
10.1158/2159-8290.cd-14-1228	Mitochondrial One-Carbon Metabolism Maintains Redox Balance during Hypoxia	I. Martinez-Reyes, N. S. Chandel	Cancer Discovery	2014	7	7	5
10.1158/2159-8290.cd-14-1507	HIF2 -Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma	B. Qiu, D. Ackerman, D. J. Sanchez, B. Li, J. D. Ochocki, A. Grazioli, E. Bobrovnikova-Marjon, J. A. Diehl, B. Keith, M. C. Simon	Cancer Discovery	2015	8	7	3
10.1158/2159-8290.cd-nb2015-095	Device Captures CTC Clusters in Blood		Cancer Discovery	2015	7	7	4
10.1158/2159-8290.cd-rw2015-141	The ABC Subtype of Diffuse Large B-Cell Lymphoma Is Responsive to Ibrutinib		Cancer Discovery	2015	7	7	3
10.1158/2326-6066.cir-14-0112	NF- B, an Active Player in Human Cancers	Y. Xia, S. Shen, I. M. Verma	Cancer immunology research	2014	7	7	3
10.1158/2326-6066.cir-14-0114	Targeting CD20+ Aggressive B-cell Non-Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice	Y. Chu, J. Hochberg, A. Yahr, J. Ayello, C. van de Ven, M. Barth, M. Czuczman, M. S. Cairo	Cancer immunology research	2014	8	7	2
10.1158/2326-6066.cir-15-0004	SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells	H. Yu, Y. Liu, B. C. McFarland, J. S. Deshane, D. R. Hurst, S. Ponnazhagan, E. N. Benveniste, H. Qin	Cancer immunology research	2015	7	7	4
10.1158/2326-6066.cir-15-0047	Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer	K. Urbanska, C. Stashwick, M. Poussin, D. J. Powell	Cancer immunology research	2015	9	7	4
